ANL

Adlai Nortye Ltd.

Nasdaq · Pharmaceutical Preparations · Inc. DE · CIK 0001944552
$10.84 +5.96% $745.4M
Vol
Market Cap$745.4M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (89%)
Inst. Holders2 funds
Inst. Value$7.8K
Inst. Activity0 buys / 1 sells
Insider Activity0B / 1S
Insider Net $-$131.80
SEC Reports2
Press Releases1
Exchange Nasdaq·Sector Pharmaceutical Preparations·Inc. DE·CIK 0001944552·Prev Close $10.23

Recent Activity

May 13, 2026 Insider
LU YANG sold 10 shares
CEO @ $13.18 ($131.80)
Apr 30, 2026 short_interest
FTD: ANL — 75,331 shares ($1.1M) failed to deliver
Settlement: 20260430, Price: $14.09, FTD Value: $1,061,413.79, ADLAI NORTYE LTD. SPONSORED AD
Apr 16, 2026 SEC
Adlai Nortye Ltd. announced a $150 million private placement of 11,320,755 ADS at $13.25 per ADS, priced at the prior da
6-K — Impact 5/10
Apr 16, 2026 Press
Adlai Nortye Ltd. announced a $150 million private placement of 11,320,755 ADSs at $13.25 per share, priced at the April
Impact 5/10
Apr 10, 2026 SEC
Adlai Nortye Ltd. reported a reduced net loss of $35.5 million in 2025, driven by lower R&D and administrative expenses,
20-F — Impact 6/10
Inst.
MORGAN STANLEY — TRIM
25 shares ($45.00)
Inst.
MORGAN STANLEY — DOUBLED
65 shares ($96.00)

Price Targets

$28.60 +163.8% upside Strong Buy
Current $10.84 Low $20.00 Median $23.00 High $46.00 5 analysts
$20.00 $46.00

Analyst Ratings

Strong Buy89% buy · 9 analysts
3Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 28, 2026 Oppenheimer INITIATE Outperform
May 14, 2026 Jones Trading INITIATE Buy
Apr 20, 2026 HC Wainwright & Co. MAINTAIN Buy → Buy
Feb 13, 2026 HC Wainwright & Co. UPGRADE Neutral → Buy

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Next Q $-0.35 $-0.35 — $-0.35 1
Current FY $-0.31 ▼ -39.1% $-0.65 — $-0.16 17% YoY 5
Next FY $-0.40 ▼ -14.5% $-0.64 — $-0.25 -29% YoY 4

Top Institutional Holders

FundValueMove
UBS Group AG$7.7KDOUBLED
MORGAN STANLEY$45.00TRIM

Recent Insider Trades

DateInsiderTypeValue
May 13, 2026LU YANGSELL$131.80
2 institutional holders with $7.8K total value (4,316 shares) as of 2025-Q3. Top holders: UBS, MORGAN. Net selling activity: 1 institutions trimmed/exited vs 0 added.

Top Institutional Holders — 2025-Q3

#FundSharesValue% of TrackedLast Move
1UBS Group AG4,291$7.7K99.4%DOUBLED +467400.0%
2MORGAN STANLEY25$45.000.6%TRIM -61.5%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
MORGAN STANLEYTRIM6525-61.5%$45.002025-Q3
MORGAN STANLEYDOUBLED1965+242.1%$96.002025-Q2
UBS Group AGDOUBLED14,675+467400.0%$9.4K2025-Q1
UBS Group AGNEAR_EXIT1,1381-99.9%$3.002024-Q4
1 unique insiders with 1 transactions. Net insider value: -$131.80 ($0.00 bought, $131.80 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
May 13, 2026LU YANGCEOSELL10$13.18$131.80
Current analyst consensus: Strong Buy (89% buy). Based on 9 analysts: 3 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$28.60 mean target +163.8% upside Strong Buy (1.00)
$20.00 Low $46.00 High
MetricValue
Current Price$10.84
Target Low$20.00
Target Mean$28.60
Target Median$23.00
Target High$46.00
# Analysts5
RecommendationStrong Buy (1.00)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-03-31
$0.00 $0.00 $0.00 $0.0B 1
Next Q
2026-06-30
$-0.35 $-0.35 $-0.35 $0.0B 1
Current FY
2026-12-31
$-0.31 $-0.65 $-0.16 17.3% -39.1% 2↑ 0↓ $0.0B 10.0% 5
Next FY
2027-12-31
$-0.40 $-0.64 $-0.25 -29.1% -14.5% 0↑ 1↓ $0.0B -97.7% 4

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$0.000
7d ago$0.000
30d ago$0.000
60d ago$0.000
90d ago$0.000
3 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 2 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 28, 2026 Oppenheimer INITIATE Outperform
May 14, 2026 Jones Trading INITIATE Buy
Apr 20, 2026 HC Wainwright & Co. MAINTAIN Buy Buy
Feb 13, 2026 HC Wainwright & Co. UPGRADE Neutral Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20263510089%
May 1, 20262410086%
Apr 1, 20262410086%
Mar 1, 20261410083%
Feb 1, 20261320067%
Jan 1, 2026003410%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

Recent Reddit Threads

r/pennystocks Bullish 1mo ago
06 MAY 2026 , WHAT ARE THER BIGGEST WINNERS AND WHY ?
▲ 1 💬 1 ⚡ 0.5
Apr 30, 2026
short_interest
FTD: ANL — 75,331 shares ($1.1M) failed to deliver
Settlement: 20260430, Price: $14.09, FTD Value: $1,061,413.79, ADLAI NORTYE LTD. SPONSORED AD
Apr 29, 2026
short_interest
FTD: ANL — 267,548 shares ($3.3M) failed to deliver
Settlement: 20260429, Price: $12.17, FTD Value: $3,256,059.16, ADLAI NORTYE LTD. SPONSORED AD
Apr 16, 2026
activist
Adlai Nortye Announces $150.0 Million Private Placement Equity Financing
<p align="justify">SINGAPORE and NORTH BRUNSWICK, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (Nasdaq: ANL) (the “Company” or “Adlai
Feb 11, 2026
short_interest
FTD: ANL — 61,216 shares ($0.6M) failed to deliver
Settlement: 20260211, Price: $9.74, FTD Value: $596,243.84, ADLAI NORTYE LTD. SPONSORED AD
Feb 3, 2026
short_interest
FTD: ANL — 121,150 shares ($1.1M) failed to deliver
Settlement: 20260203, Price: $9.27, FTD Value: $1,123,060.5, ADLAI NORTYE LTD. SPONSORED AD
Feb 2, 2026
short_interest
FTD: ANL — 235,572 shares ($2.5M) failed to deliver
Settlement: 20260202, Price: $10.63, FTD Value: $2,504,130.36, ADLAI NORTYE LTD. SPONSORED AD